david charles

April 3, 2014

DBS for Parkinson’s trial moves to next level

A long-term Vanderbilt University Medical Center study of deep brain stimulation (DBS) in early-stage Parkinson’s disease has received approval from the Food and Drug Administration (FDA) to continue in a pivotal, phase III, large-scale safety and efficacy trial.

By VUMC News and Communications

September 5, 2013

Cervical dystonia patients find answers, treatment at VUMC

By VUMC News and Communications

December 13, 2012

New Neurology residency program director brings global perspective

After a decade of growth in the Department of Neurology’s residency program, Heather Koons, M.D., is stepping into the role of program director and brings a uniquely international perspective.

By VUMC News and Communications

September 7, 2012

Parkinson’s therapy may impact language

Deep brain stimulation used to treat Parkinson’s disease may impair some aspects of language processing, a recent study suggests.

By VUMC News and Communications

August 23, 2012

Events honor early patients of novel Parkinson’s study

Pioneers of Parkinson’s disease research are gathering at Vanderbilt University Medical Center today to celebrate the end of a study that was an important first step in the quest to find a way to slow the progression of the degenerative movement disorder.

By VUMC News and Communications